Dong-A ST and Hallim Pharmaceutical Join Hands to Expand Ophthalmic Drug Exports

Dong-A ST (Dong-A ST) announced on the 18th that it signed a business agreement with Hallim Pharmaceutical on the 17th at its headquarters in Yongdu-dong, Dongdaemun-gu, Seoul, to export ophthalmic solutions and improved new drugs.

At the signing ceremony of the export business agreement for ophthalmic solutions and improved new drugs between Dong-A ST and Hanlim Pharm, Kim Min-young, President of Dong-A ST (left), and Kim Jeong-jin, Vice Chairman of Hanlim Pharm, are taking a commemorative photo.
[Photo by Dong-A ST]

The agreement ceremony was attended by Kim Min-young, President of Dong-A ST, Kim Jeong-jin, Vice Chairman of Hallim Pharmaceutical, Lee Jin-su, Vice President of Hallim Pharmaceutical, and other officials. The agreement was established to pioneer overseas markets and secure future growth engines based on synergy through cooperation between the two companies.

According to the agreement, Hallim Pharmaceutical will provide ophthalmic solutions and improved new drugs to Dong-A ST, and Dong-A ST will export Hallim Pharmaceutical's ophthalmic solutions and improved new drugs to Dong-A ST's major export countries in cooperation with Hallim Pharmaceutical.

A Dong-A ST official said, "If the two companies cooperate based on their competitiveness, they will be able to create new synergy," adding, "We plan to actively seek business opportunities that can generate synergy by cooperating with various companies in the future."

This content was produced with the assistance of AI translation services.